Progress of correlation between clinical hematologic parameters and prognosis of cervical cancer
10.3760/cma.j.cn115355-20200220-00062
- VernacularTitle:临床血液学参数与子宫颈癌预后相关性的研究进展
- Author:
Ning ZHANG
1
;
Linqing YANG
;
Xiaoyu LI
;
Jing XU
Author Information
1. 济宁医学院临床医学院，山东 济宁 272067
- From:
Cancer Research and Clinic
2020;32(8):593-596
- CountryChina
- Language:Chinese
-
Abstract:
Clinical hematologic parameters refer to the reference data of blood tests such as routine blood and blood biochemistry. Inflammatory cells and inflammatory mediators are important components of the tumor microenvironment and play an important role in the process of tumor occurrence and development. This article reviews that clinical hematologic parameters have special clinical reference significance for cervical cancer invasion and metastasis, radiotherapy response and prognosis evaluation through analysis of clinical hematologic parameters and cervical cancer prognosis studies, such as the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio.
